Image
Insights
In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.
Image
Can AI and Machine Learning in Sterile Manufacturing Improve Quality?
Image
Optimising Clinical Trial Data Collection for Better Decisions
Image
What Drives Pharmaceutical R&D Success? New Benchmarking Reveals Why Some Drug Pipelines Outperform Others
Biomedical R&D
Image
Can Large Language Models Solve More Rare Disease Genomes?
AI & Machine Learning
Image
Can Large Language Models Solve More Rare Disease Genomes?
AI & Machine Learning
Image
Modular Pharma Factories: The Next Step for Continuous Manufacturing?
Continuous Manufacturing
Explore All Insights
Browse our complete library of expert articles and analysis. Explore content across science, policy and life sciences innovation.
Can AI and Machine Learning in Sterile Manufacturing Improve Quality?
Discover how AI/ML in sterile pharmaceutical manufacturing enables predictive maintenance, quality control, contamination detection, and intelligent GMP operations.
What Drives Pharmaceutical R&D Success? New Benchmarking Reveals Why Some Drug Pipelines Outperform Others
Explore new benchmarking research on pharmaceutical R&D success rates, revealing why some drug pipelines consistently achieve higher approval rates than others.
Modular Pharma Factories: The Next Step for Continuous Manufacturing?
Discover how modular pharmaceutical manufacturing and continuous production could improve flexibility, resilience, and efficiency across modern pharmaceutical operations.
Success for Non-Animal Testing of Preclinical Toxicity?
Can non-animal testing methods be used in preclinical drug discovery? Here is what the evidence is for their accuracy and limits assessing preclinical toxicity.
Why CMC Strategy Defines Cell and Gene Therapy Success
Cell and gene therapy CMC strategies, quality systems, and manufacturing innovation are critical to advanced therapy development and determine scalability.
Great Drug Discovery Starts with Great Scientists
Learn how drug discovery scientists are evolving alongside AI, computational biology, and multidisciplinary research to accelerate therapeutic innovation.
One Global CMC Dossier? Digital Regulatory Submissions
Discover how digital CMC regulatory submissions, cloud collaboration, and AI accelerate the modernisation of manufacturing approvals and global pharma operations.
GLP-1 Drug Discovery Success Transformed Pharmaceutical R&D
From gut hormones to global therapeutics, GLP-1 drug discovery transformed obesity treatment through peptide engineering and incretin biology translation.
FDA PreCheck Pilot Program to Build Manufacturing Readiness
The FDA PreCheck Pilot Program aims to strengthen U.S. domestic drug manufacturing through regulatory engagement, manufacturing readiness, and advanced production.
Can Deep Learning Survive the Precision Medicine Paradox?
As precision medicine narrows patient cohorts to rare‑disease scales, deep learning models face a paradox of data scarcity and overfitting that threatens the future of clinical AI.
Genomic Governance Ensures Equity at the Core of Drug Discovery
Discover why genomic equity is essential for reliable AI-driven drug discovery, precision medicine, and building more representative pharmaceutical innovation.
FDA Registration for Drug Manufacturing Enters a New Era
The FDA's proposed drug manufacturing modernisation rule could accelerate distributed manufacturing, digital quality systems, and pharma supply chain resilience.
